| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% | 
| Div Cover | n/a | n/a | 
| Op Mrgn | -8.4% | n/a | 
| ROCE | n/a | 
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a | 
| PEG | n/a | n/a | 
| Pr/Revenue | 0.4 | n/a | 
| Pr/Book | 2.1 | 
| Latest | F'cast | |
|---|---|---|
| Revenue | -6.8% | n/a | 
| PBT | n/a | n/a | 
| EPS | n/a | n/a | 
| DPS | n/a | n/a | 
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield | 
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1,613.62 | (534.64) | (66.00)p | n/a | n/a | n/a | n/a | 0.0% | 
| 31-Dec-21 | 2,179.91 | (186.29) | (13.00)p | n/a | n/a | n/a | n/a | 0.0% | 
| 31-Dec-22 | 2,239.23 | (549.73) | (44.00)p | n/a | n/a | n/a | n/a | 0.0% | 
| 31-Dec-23 | 1,879.90 | (92.25) | 8.00p | 10.6 | n/a | n/a | n/a | 0.0% | 
| 31-Dec-24 | 1,751.40 | (202.40) | (13.00)p | n/a | n/a | n/a | n/a | 0.0% | 
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Block listing Interim Review | 03-Nov-2025 | 07:00 | RNS | 
| Director Declaration | 28-Oct-2025 | 11:14 | RNS | 
| Q3 2025 Trading Statement | 14-Oct-2025 | 07:00 | RNS | 
No deals were found in the last 28 days.
| Currency | UK Pounds | 
| Share Price | 45.94p | 
| Change Today | -0.54p | 
| % Change | -1.16 % | 
| 52 Week High | 53.90 | 
| 52 Week Low | 22.96 | 
| Volume | 1,955,342 | 
| Shares Issued | 1,390.69m | 
| Market Cap | £638.89m | 
| RiskGrade | 166 | 
| Value | 
		 | 
		
|---|
| Price Trend | 
		 | 
		
|---|
| Income | ![]()  | 
				
|---|
| Growth | 
		 | 
		
|---|
| No dividends found | 
| Time | Volume / Share Price | 
| 16:35 | 540 @ 45.94p | 
| 16:35 | 3,368 @ 45.94p | 
| 16:35 | 3,368 @ 45.94p | 
| 16:35 | 3,368 @ 45.94p | 
| 16:35 | 622,895 @ 45.94p | 
| CEO | Matthew Moulding | 
| CFO | Damian Sanders | 
| Chair | Charles Allen | 
You are here: research